Deutsche Bank AG Grows Position in Henry Schein, Inc. (NASDAQ:HSIC)

Deutsche Bank AG raised its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 21.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 647,022 shares of the company's stock after buying an additional 112,408 shares during the quarter. Deutsche Bank AG owned 0.52% of Henry Schein worth $44,774,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in HSIC. Olstein Capital Management L.P. lifted its stake in shares of Henry Schein by 17.2% during the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock worth $7,543,000 after buying an additional 16,000 shares during the last quarter. Private Management Group Inc. increased its position in shares of Henry Schein by 5.7% during the fourth quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock valued at $24,256,000 after buying an additional 18,882 shares during the period. Equitable Trust Co. bought a new position in shares of Henry Schein in the 4th quarter worth $417,000. Savant Capital LLC grew its holdings in Henry Schein by 43.9% in the 4th quarter. Savant Capital LLC now owns 4,651 shares of the company's stock worth $322,000 after acquiring an additional 1,420 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Henry Schein by 29.9% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company's stock valued at $1,113,000 after purchasing an additional 3,650 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Wall Street Analysts Forecast Growth

HSIC has been the subject of several recent research reports. StockNews.com lowered Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Piper Sandler decreased their price objective on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. Jefferies Financial Group boosted their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. Wells Fargo & Company reduced their price objective on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Finally, Barrington Research lowered their price objective on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research report on Tuesday, May 6th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $79.30.

Henry Schein Trading Down 0.4%

Shares of Henry Schein stock traded down $0.26 on Monday, hitting $71.79. 229,240 shares of the company traded hands, compared to its average volume of 1,736,082. The company has a market cap of $8.74 billion, a PE ratio of 29.54, a PEG ratio of 2.13 and a beta of 0.87. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The stock's 50 day moving average price is $67.34 and its 200-day moving average price is $71.47.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter in the prior year, the firm posted $1.10 EPS. The business's quarterly revenue was down .1% compared to the same quarter last year. Equities research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Insider Activity at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. The trade was a 6.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares in the company, valued at approximately $1,762,147.20. This represents a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is owned by corporate insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.